Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 4. mars 2024 kl. 13:11 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Harald Gurvin | CFO | Kjøp | 20 000 | 16,59 NOK | 4. mars 2024 | NO0010714785 | XOSL |
Vedlegg
- Attachment 240304.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, March 4, 2024 - Primary insider Harald Gurvin, Chief Financial Officer of Nykode Therapeutics ASA, has today acquired 20,000 shares in Nykode Therapeutics ASA at an average price of NOK 16.59 per share.
Please see further details in the attached document.